EYPT
EYPT
NASDAQ · Pharmaceuticals

Eyepoint Inc

$13.89
+1.06 (+8.26%)
As of Aug 8, 10:11 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -33.7% upside
Low Target $6.71
Average Target $9.21
High Target $14.14
Current Price $13.89
Current
$13.89
Target
$9.21
$6.71 $9.21 avg $14.14
Scenario Analysis
Bear Case
$6.71
-51.7%
Low target
Base Case
$9.21
-33.7%
Avg target
Bull Case
$14.14
+1.8%
High target
Risk/Reward
0.0x
Unfavorable
Price in Context
52-Week High
$19.11
-27.3% from high
52-Week Low
$9.51
+46.1% from low
Target vs 52W High
$9.21
-51.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%